Taiwan - Delayed Quote TWD
Panion & Bf Biotech Inc. (1760.TW)
66.40
+0.10
+(0.15%)
At close: 1:30:22 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,029,645
2,029,645
1,881,875
2,398,648
1,901,211
Cost of Revenue
959,373
959,373
907,478
1,080,052
989,073
Gross Profit
1,070,272
1,070,272
974,397
1,318,596
912,138
Operating Expense
855,096
855,096
818,620
904,554
744,706
Operating Income
215,176
215,176
155,777
414,042
167,432
Net Non Operating Interest Income Expense
-7,585
-7,585
-4,837
-5,792
-14,043
Pretax Income
217,435
217,435
168,711
333,409
182,652
Tax Provision
92,912
92,912
91,492
151,064
78,250
Net Income Common Stockholders
124,523
124,523
77,219
182,345
104,402
Diluted NI Available to Com Stockholders
124,523
124,523
77,219
182,345
104,402
Basic EPS
1.45
--
0.90
2.13
1.32
Diluted EPS
1.45
--
0.90
2.12
1.32
Basic Average Shares
85,877.93
--
85,798.89
85,739
79,180
Diluted Average Shares
85,877.93
--
85,798.89
85,828
79,236
Total Expenses
1,814,469
1,814,469
1,726,098
1,984,606
1,733,779
Net Income from Continuing & Discontinued Operation
124,523
124,523
77,219
182,345
104,402
Normalized Income
124,263
124,263
76,377.40
182,407.40
106,074
Interest Income
7,437
7,437
6,520
1,793
638
Interest Expense
15,022
15,022
11,357
7,585
14,681
Net Interest Income
-7,585
-7,585
-4,837
-5,792
-14,043
EBIT
232,457
232,457
180,068
340,994
197,333
EBITDA
396,881
396,881
350,458
504,541
340,956
Reconciled Cost of Revenue
959,373
959,373
907,478
1,080,052
989,073
Reconciled Depreciation
164,424
164,424
170,390
163,547
143,623
Net Income from Continuing Operation Net Minority Interest
124,523
124,523
77,219
182,345
104,402
Total Unusual Items Excluding Goodwill
325
325
1,052
-78
-2,090
Total Unusual Items
325
325
1,052
-78
-2,090
Normalized EBITDA
396,556
396,556
349,406
504,619
343,046
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
65
65
210.40
-15.60
-418
12/31/2021 - 12/20/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
28.10
-0.35%
4133.TW Abnova (Taiwan) Corporation
27.35
+3.60%
4162.TWO PharmaEngine, Inc.
87.70
+0.34%
6589.TWO EirGenix Inc.
61.50
-0.81%
1734.TW Sinphar Pharmaceutical Co.,Ltd.
31.15
-0.16%
1733.TW Apex Biotechnology Corp.
32.20
+0.31%
4743.TWO Oneness Biotech Co., Ltd.
60.30
-1.63%
4147.TWO TaiMed Biologics Inc.
79.60
-1.24%
4142.TW Adimmune Corporation
18.15
-2.68%
3164.TW GenMont Biotech Incorporation
19.45
+1.04%